< Back to situations

[ORGANIZATION]

New England Journal of Medicine

Featured in 8 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

213 clusters · 797 sources · last updated

Latest: GLP-1 weight-loss programs combine medication with lifestyle support

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili

[ACTIVE] [CULTURE] [US]

Scrutiny of academic and scientific institutional integrity

2 clusters · 4 sources · last updated

Latest: Institutional integrity faces scrutiny in science and academia

Debates regarding the integrity of academic and scientific institutions have centered on concerns over ideological bias and the decline of intellectual rigor. In higher education, critics have highlighted the influence o

[QUIET] [HEALTH] [AU] [DE] [GB]

Global tobacco health awareness and cessation gaps

2 clusters · 8 sources · last updated

Latest: Global tobacco control faces gaps in cessation support and health awareness

Recent global research highlights significant deficiencies in public awareness regarding the health risks of tobacco use and a lack of adequate cessation support. An international analysis of 240,000 adults across 46 cou

[QUIET] [HEALTH] [BE] [CH] [DE]

Clinical applications of CAR-T cell therapy

2 clusters · 4 sources · last updated

Latest: CAR-T cell therapy advances treatment for aggressive lymphomas

CAR-T cell therapy is demonstrating expanding clinical utility across different medical applications. Research published in the New England Journal of Medicine indicates that the therapy can enable safe pregnancies for w

Also covered in